Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home
- Disease/Condition
- Pulmonary Disease, Chronic Obstructive
- Drug/Device/Intervention
- health education
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Necmettin Erbakan University
- Phase
- N/A
- Start date
- Feb 15, 2023
- End date
- Aug 15, 2023
- Enrollment
- 74 participants
number of hospital admissions,number of hospital admissions,number of hospital admissions
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by
 persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin
 deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity
 and mortality associated with COPD acute exacerbations represent a significant public health
 problem that places a high burden on patients, their families and society. In frequent and
 severe exacerbations, patients may experience a decrease in quality of life, depression, and
 even death up to one year after hospitalization. Costs associated with COPD are more than
 $15.5 billion, and hospitalizations and repeated hospital admissions related to acute
 exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce
 hospital admissions and hospitalizations associated with recurrent exacerbations are
 imperative to improve patient's quality of life and reduce the societal burden.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05730088
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05730088 through Pure Global AI's free database. This phase not specified trial is sponsored by Necmettin Erbakan University and is currently Not yet recruiting. The study focuses on Pulmonary Disease, Chronic Obstructive. Target enrollment is 74 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.